These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9713510)

  • 1. Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins.
    Eid H; Géczi L; Mágori A; Bodrogi I; Institoris E; Bak M
    Anticancer Res; 1998; 18(4C):3059-64. PubMed ID: 9713510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic value of the lung resistance-related protein (LRP) in germ cell testicular tumors.
    Mándoky L; Géczi L; Doleschall Z; Bodrogi I; Csuka O; Kásler M; Bak M
    Anticancer Res; 2004; 24(2C):1097-104. PubMed ID: 15154630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of MDR1-expression in testicular germ cell cancer.
    Schrader AJ; Seger M; Konrad L; Olbert P; Hegele A; Hofmann R; Heidenreich A
    Exp Oncol; 2007 Sep; 29(3):212-6. PubMed ID: 18004247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma.
    Siu LL; Banerjee D; Khurana RJ; Pan X; Pflueger R; Tannock IF; Moore MJ
    Clin Cancer Res; 1998 Mar; 4(3):559-65. PubMed ID: 9533522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
    Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants of treatment response in human germ cell tumors.
    Mayer F; Stoop H; Scheffer GL; Scheper R; Oosterhuis JW; Looijenga LH; Bokemeyer C
    Clin Cancer Res; 2003 Feb; 9(2):767-73. PubMed ID: 12576448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
    Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.
    Joseph MG; Banerjee D; Kocha W; Feld R; Stitt LW; Cherian MG
    Cancer; 2001 Aug; 92(4):836-42. PubMed ID: 11550155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance of testis cancers: the study of clinical relevance of P-glycoprotein expression.
    Eid H; Bodrogi I; Csókay B; Oláh E; Bak M
    Anticancer Res; 1996; 16(6B):3447-52. PubMed ID: 9042205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metallothionein expression as a marker of therapeutic sensitivity in the early stages of testicular cancer].
    Eid H; Institoris E; Bodrogi I; Bak M
    Orv Hetil; 1997 Jan; 138(3):135-9. PubMed ID: 9064626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
    Beck WT; Grogan TM; Willman CL; Cordon-Cardo C; Parham DM; Kuttesch JF; Andreeff M; Bates SE; Berard CW; Boyett JM; Brophy NA; Broxterman HJ; Chan HS; Dalton WS; Dietel M; Fojo AT; Gascoyne RD; Head D; Houghton PJ; Srivastava DK; Lehnert M; Leith CP; Paietta E; Pavelic ZP; Weinstein R
    Cancer Res; 1996 Jul; 56(13):3010-20. PubMed ID: 8674056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is p53 expression, detected by immunohistochemistry, an important parameter of response to treatment in testis cancer?
    Eid H; Van der Looij M; Institoris E; Géczi L; Bodrogi I; Oláh E; Bak M
    Anticancer Res; 1997; 17(4A):2663-9. PubMed ID: 9252698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
    Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA
    Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment.
    Mandoky L; Szende B; Géczi L; Bodrogi I; Kásler M; Bak M
    Anticancer Res; 2008; 28(3A):1641-9. PubMed ID: 18630521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does a low frequency of P53 and Pgp expression in familial glioma compared to sporadic controls indicate biological differences?
    Malmer B; Brännström T; Andersson U; Bergh K; Grönberg H; Henriksson R
    Anticancer Res; 2002; 22(6C):3949-54. PubMed ID: 12553017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
    Bottini A; Berruti A; Bersiga A; Brizzi MP; Brunelli A; Gorzegno G; DiMarco B; Aguggini S; Bolsi G; Cirillo F; Filippini L; Betri E; Bertoli G; Alquati P; Dogliotti L
    Clin Cancer Res; 2000 Jul; 6(7):2751-8. PubMed ID: 10914720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
    Mazumdar M; Bacik J; Tickoo SK; Dobrzynski D; Donadio A; Bajorin D; Motzer R; Reuter V; Bosl GJ
    J Clin Oncol; 2003 Jul; 21(14):2679-88. PubMed ID: 12860944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer.
    Pastuszewski W; Dziegiel P; Krecicki T; Podhorska-Okolow M; Ciesielska U; Gorzynska E; Zabel M
    Anticancer Res; 2007; 27(1A):335-42. PubMed ID: 17352251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.